A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the developed world. Monthly or as-needed (PRN) dosing strategies of intravitreal ranibizumab have been established as efficacious treatment options for neovascular AMD. More recently, the ‘treat-and-extend’ dos...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eye (Lond)
Auteurs principaux: Rufai, S R, Almuhtaseb, H, Paul, R M, Stuart, B L, Kendrick, T, Lee, H, Lotery, A J
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2017
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601449/
https://ncbi.nlm.nih.gov/pubmed/28475181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.67
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires